Skip to main content

Want a detailed portfolio tracker?

Exelixis (EXEL) P/E (2011 - 2026)

Exelixis (EXEL) P/E from Sep 30, 2011 to Jun 3, 2026. The TTM Exelixis (EXEL) P/E is 16.29. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Exelixis (EXEL)

YearP/EChange
202616.29-7.71%
202517.65-14.42%
202420.63-43.05%
202336.21+28.14%
202228.26+12.80%
202125.06-37.92%
202040.36+365.92%
20198.66+1.69%
20188.52-85.61%
201759.19-340.61%
2016-24.60+234.50%
2015-7.35+583.86%
2014-1.08-77.31%
2013-4.74-9.58%
2012-5.24-166.75%
20117.85N/A

Comparison Exelixis (EXEL) P/E with competitors

Exelixis (EXEL) P/E is 16.29.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-99.99%
NBYStablecoin Development Corp0.10-99.37%
ENLVEnlivex Therapeutics Ltd0.15-99.08%
FGENFibroGen Inc0.24-98.53%
TRAWTraws Pharma Inc0.47-97.10%
FBIOFortress Biotech Inc0.71-95.67%
CHRSCoherus Biosciences Inc0.98-94.00%
ORMPOramed Pharmaceuticals Inc1.47-90.96%
AGENAgenus Inc2.05-87.43%
VIVSVivoSim Labs Inc2.54-84.43%
INVAInnoviva Inc3.19-80.43%
CRMDCorMedix Inc3.65-77.62%
ABEOAbeona Therapeutics Inc4.20-74.19%
VXRTVaxart Inc4.26-73.84%
CVACCureVac N.V.4.45-72.71%
SRPTSarepta Therapeutics Inc4.62-71.61%
GLPGGalapagos NV4.86-70.17%
RIGLRigel Pharmaceuticals4.92-69.80%
ZVRAZevra Therapeutics Inc4.97-69.47%
ABUSArbutus Biopharma Corp5.69-65.05%
CGENCompugen Ltd7.38-54.67%
AUPHAurinia Pharmaceuticals Inc9.25-43.21%
ACADAcadia Pharmaceuticals Inc9.59-41.14%
OMEROmeros Corporation9.88-39.33%
PLXProtalix BioTherapeutics Inc9.91-39.17%
SPROSpero Therapeutics Inc10.73-34.10%
ADMAAdma Biologics Inc11.33-30.45%
SVASinovac Biotech Ltd11.44-29.80%
TBPHTheravance Biopharma Inc11.78-27.71%
HRMYHarmony Biosciences Holdings Inc12.18-25.23%
TGTXTG Therapeutics Inc13.18-19.10%
INCYIncyte Corp13.38-17.85%
SABSSAB Biotherapeutics Inc14.06-13.71%
XOMAXOMA Corp14.95-8.26%
REGNRegeneron Pharmaceuticals Inc14.98-8.04%
PBYIPuma Biotechnology Inc15.05-7.61%
NAGENiagen Bioscience Inc16.35+0.40%
CPRXCatalyst Pharmaceuticals Inc17.34+6.47%
MDXGMimedx Group Inc17.38+6.66%
ARGXArgen X SE23.07+41.63%
HALOHalozyme Therapeutics Inc23.20+42.42%
XOMAOXOMA Corp25.34+55.58%
VRTXVertex Pharmaceuticals Inc25.66+57.49%
XOMAPXOMA Corp25.67+57.58%
CTMXCytomX Therapeutics Inc25.70+57.75%
ASNDAscendis Pharma A/S26.35+61.78%
RPRXRoyalty Pharma plc - Class A27.50+68.78%
SLNOSoleno Therapeutics Inc29.02+78.11%
LGNDLigand Pharmaceuticals Inc - Class B30.19+85.30%
BMRNBiomarin Pharmaceutical Inc37.51+130.24%
APLSApellis Pharmaceuticals Inc39.02+139.54%
KRYSKrystal Biotech Inc39.70+143.69%
GMABGenmab40.20+146.79%
ONCBeiGene Ltd67.03+311.45%
TECHBio-Techne Corp68.59+321.08%
VCELVericel Corp80.63+394.95%
PHARPharming Group N.V.87.74+438.60%
ALNYAlnylam Pharmaceuticals Inc124.93+666.92%
TLXTelix Pharmaceuticals Ltd139.89+758.74%
CORTCorcept Therapeutics Inc158.39+872.29%